Nicoletta Loggia - 07 Jun 2023 Form 4 Insider Report for Candel Therapeutics, Inc. (CADL)

Role
Director
Signature
/s/ Jason A. Amello, as Attorney-In-Fact for Nicoletta Loggia
Issuer symbol
CADL
Transactions as of
07 Jun 2023
Net transactions value
$0
Form type
4
Filing time
09 Jun 2023, 08:45:06 UTC
Next filing
27 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CADL Stock Option (Right to Buy) Award $0 +28,480 $0.000000 28,480 07 Jun 2023 Common Stock 28,480 $1.51 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option shall vest and become exercisable in 36 equal monthly installments, subject to the Reporting Person's continued service on each such vesting date.